7-129774734-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NR_029512.1(MIR96):n.36T>C variant causes a non coding transcript exon change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 474,422 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0031 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0034 ( 4 hom. )
Consequence
MIR96
NR_029512.1 non_coding_transcript_exon
NR_029512.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 8.60
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 7-129774734-A-G is Benign according to our data. Variant chr7-129774734-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 163977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-129774734-A-G is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIR96 | NR_029512.1 | n.36T>C | non_coding_transcript_exon_variant | 1/1 | ||||
MIR96 | unassigned_transcript_1306 use as main transcript | n.-16T>C | upstream_gene_variant | |||||
MIR96 | unassigned_transcript_1307 use as main transcript | n.*5T>C | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIR96 | ENST00000362288.1 | n.36T>C | non_coding_transcript_exon_variant | 1/1 | 6 | |||||
ENSG00000286380 | ENST00000710872.1 | n.431+5056T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00309 AC: 470AN: 152086Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
470
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00295 AC: 477AN: 161596Hom.: 3 AF XY: 0.00283 AC XY: 241AN XY: 85152
GnomAD3 exomes
AF:
AC:
477
AN:
161596
Hom.:
AF XY:
AC XY:
241
AN XY:
85152
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00340 AC: 1095AN: 322218Hom.: 4 Cov.: 0 AF XY: 0.00317 AC XY: 577AN XY: 181844
GnomAD4 exome
AF:
AC:
1095
AN:
322218
Hom.:
Cov.:
0
AF XY:
AC XY:
577
AN XY:
181844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00309 AC: 470AN: 152204Hom.: 4 Cov.: 33 AF XY: 0.00316 AC XY: 235AN XY: 74422
GnomAD4 genome
AF:
AC:
470
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
235
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 15, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | MIR96: BS2 - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 05, 2013 | 36T>C in Exon 1 of MIR96: This variant is not expected to have clinical signific ance because it has been identified in 0.7% (5/725) of American European and Eur opean chromosomes by the 1000 Genome Project (http://www.1000genomes.org/; dbSNP rs41274239) as well as 0.4% (28/7102) of European American chromosomes from a b road population by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/), and is not located in the seed region of the miRNA. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at